Watermark
  Back to Search Results

BGB-290-103

Completed

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-290-103

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03150810

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2017

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan